Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Teladoc Health, Inc.NYSE: TDOC

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q1 FY2026 gross profit of $324.03M fell 25.1% year over year, behind the -8.3% change in trailing-twelve-month gross profit. Sequentially, it fell 27.2% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.

Context

  • Gross profit amounted to 69.5% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -25.1% toward the trailing-twelve-month pace of -8.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$324.03M-27.2% QoQ
Last fiscal yearDec 2025
$1.76B-3.3% YoY
LTMMar 2026
$1.65B-8.3% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-25.1%——
1 year-3.3%——
3-year CAGR+1.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
1.76B USD
Year-over-year change
-3.3%
4-year CAGR
+6.2%

Gross Profit vs competitors

How TDOC compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -8.3% is the 9th highest of 11, against a peer median of +7.1%.
  • Gross profit amounts to 65.6% of revenue for TDOC, versus a peer median of 51.4%.
TDOC Competitors
Gross Profit for TDOC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TDOCTeladoc Health, Inc.LTM Mar 2026$1.65B USD-8.3%+1.9%65.6%
OMCLOmnicell, Inc.LTM Mar 2026$532.87M USD+8.5%-4.8%43.5%
NVCRNovoCure LimitedLTM Mar 2026$507.13M USD+5.7%+4.9%75.2%
PHRPhreesia, Inc.LTM Apr 2026$326.13M USD+10.3%+23.9%65.8%
PGNYProgyny, Inc.LTM Jun 2026$322.09M USD+16.1%+22.1%24.6%
AZTAAzenta, Inc.LTM Sep 2026$274.96M USD+0.1%+5.6%44.2%
OMDAOmada HealthLTM Mar 2026$187.61M USD+60.4%+58.7%66.2%
SDGRSchrödinger, Inc.LTM Sep 2026$157.53M USD+5.4%+12.2%58.5%
EVOEvotec SELTM Mar 2026€84.67M EUR-21.1%-28.9%11.4%
PHVSPharvaris N.V.LTM Sep 2026-€106.45K EUR-9.7%——
IMNMImmunome, Inc.LTM Sep 2026-$753K USD+98.1%——
Peer median (excluding TDOC) —+7.1%+8.9%51.4%

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.